Cohen David E bought EVMN
November 7, 2025 · Form 4 insider transaction
Cohen David E bought 6,056 shares of Evommune, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,056
Price
N/A
Total value
N/A
InsiderCohen David E
RoleDirector
CompanyEvommune, Inc. (EVMN)
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after23,665
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.